Investor Relations
Stock Info
TSXVCOV

Investor Relations Overview

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF) is a leading provider of advanced medical technologies designed to support the most vulnerable patient populations and improve the standard of care in pediatric and acute care hospitals.


For more than 20 years, we have successfully delivered vascular access, advanced wound care, perioperative care, and customized medical device coating solutions to patients throughout the U.S., Canada, Europe, and the Middle East. Our U.S. pediatric customer base continues to expand with four of the top five pediatric hospitals in the U.S., as ranked by U.S. News & World Report, adopting Covalon’s technology as part of their infection prevention protocols. 


We offer innovative, gentler, and more compassionate options for patients to heal with fewer infections, less pain, and better outcomes because healing shouldn’t hurt.

Press Releases
Jan 25, 2023

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2022 fourth quarter and year end results for...

Jan 23, 2023

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2022 financial results on...

Nov 21, 2022

A two-year study with the aim of preventing sternal wound infections highlights SurgiClear as a key component of the infection prevention bundle used to significantly reduce infection rates...

View All

Events
Thursday, January 26, 2023
9:00am - 10:00am EST
Thursday, November 10, 2022
1:00pm - 2:00pm EST

View All